{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:18:21Z","timestamp":1787836701358,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"abstract":"<jats:p>The Saving Kidneys, Hearts, and Lives workshop in March 2025, hosted by the American Society of Nephrology, brought together diverse stakeholders in the care of patients with cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome, including multispecialty health care professionals, patients, and researchers from academic and community-based backgrounds. The CKM syndrome encompasses multidirectional interactions among kidney diseases, cardiovascular diseases, diabetes, and obesity. Highly efficacious therapies are presently available to reduce risks of adverse kidney and cardiovascular events as well as all-cause mortality. The goal of the Saving Kidneys, Hearts, and Lives workshop was to gain insights into and make recommendations for the role of nephrology in CKM care. Following a series of plenary talks about the current state, interactive discussions among participants focused on developing tangible strategies and opportunities for nephrology in addressing CKM syndrome. Participants noted that nephrology spans internal medicine, with special expertise in managing kidney diseases, BP, and CKM risk factors along with training that emphasizes interactions among complex chronic conditions. Participants highlighted the importance of screening and implementation of CKM syndrome diagnostic and therapeutic strategies earlier than when patients have been typically referred to nephrology specialty care. In addition, participants explored the contributions of nephrologists to upstream care, beyond their conventional focus on high-risk, rare, or advanced kidney diseases. Participants recognized barriers, including payment structures that provide relatively modest resources for complex chronic care before KRT and gaps in nephrology training to manage CKM syndrome. Ongoing strategies by the American Society of Nephrology will focus on collaborations and crossing traditional specialty boundaries of nephrology, cardiology, and metabolic diseases to promote overall CKM health.<\/jats:p>","DOI":"10.2215\/cjn.0000001164","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:05:45Z","timestamp":1782749145000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Nephrology in the Paradigm of Cardiovascular\u2011Kidney\u2013Metabolic Health"],"prefix":"10.2215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"first","affiliation":[{"name":"Providence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington"},{"name":"Kidney Research Institute and Nephrology Division, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-7773","authenticated-orcid":false,"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[{"name":"Katz Family Division of Nephrology and Hypertension, University of Miami, Coral Gables, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Kliger","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-4419","authenticated-orcid":false,"given":"Bridget","family":"Kuehn","sequence":"additional","affiliation":[{"name":"SciBridge Media, Inc., Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-394X","authenticated-orcid":false,"given":"Daniel E.","family":"Weiner","sequence":"additional","affiliation":[{"name":"Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"West","sequence":"additional","affiliation":[{"name":"American Society of Nephrology, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-8401","authenticated-orcid":false,"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[{"name":"St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For Saving Kidneys Hearts Lives Conference Participants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"20","key":"B1-20260728","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"11","key":"B2-20260728","doi-asserted-by":"crossref","first-page":"e007264","DOI":"10.1161\/CIRCOUTCOMES.120.007264","article-title":"Cardio-renal-metabolic care models: toward achieving effective interdisciplinary care","volume":"13","author":"Rangaswami","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"supplment_1","key":"B3-20260728","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ndt\/gfae212","article-title":"Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease","volume":"40","author":"Alicic","year":"2025","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B4-20260728","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.kint.2025.10.004","article-title":"From progression to remission: a new paradigm for success in chronic kidney disease","volume":"109","author":"Tangri","year":"2026","journal-title":"Kidney Int."},{"issue":"4","key":"B5-20260728","doi-asserted-by":"crossref","first-page":"151660","DOI":"10.1016\/j.semnephrol.2025.151660","article-title":"Beyond kidney genes: broad clinical implications of genetic testing for nephrology patients","volume":"45","author":"Elefant","year":"2025","journal-title":"Semin Nephrol."},{"issue":"5","key":"B6-20260728","doi-asserted-by":"crossref","first-page":"e13765","DOI":"10.1111\/eci.13765","article-title":"Future of kidney imaging: functional magnetic resonance imaging and kidney disease progression","volume":"52","author":"Copur","year":"2022","journal-title":"Eur J Clin Invest."},{"issue":"1","key":"B7-20260728","doi-asserted-by":"crossref","first-page":"sfae365","DOI":"10.1093\/ckj\/sfae365","article-title":"Multiparametric MRI: can we assess renal function differently?","volume":"18","author":"Tournebize","year":"2025","journal-title":"Clin Kidney J."},{"issue":"16","key":"B8-20260728","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/jcm13164632","article-title":"A new era for PET\/CT: applications in non-tumorous renal pathologies","volume":"13","author":"Moghrabi","year":"2024","journal-title":"J Clin Med."},{"issue":"10","key":"B9-20260728","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/diagnostics15101225","article-title":"Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI","volume":"15","author":"Alobaidi","year":"2025","journal-title":"Diagnostics."},{"issue":"10365","key":"B10-20260728","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists\u2019 Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet."},{"issue":"12","key":"B11-20260728","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","article-title":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes","volume":"30","author":"Vaduganathan","year":"2024","journal-title":"Nat Med."},{"issue":"5","key":"B12-20260728","first-page":"846","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care."},{"issue":"1","key":"B14-20260728","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12882-025-03952-4","article-title":"Lived experiences of people with chronic kidney disease on maintenance dialysis: a systematic review and thematic synthesis of qualitative studies","volume":"26","author":"Elias","year":"2025","journal-title":"BMC Nephrol."},{"issue":"4","key":"B15-20260728","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.ajkd.2024.11.005","article-title":"Determinants of caregiver burden among spouses of patients with kidney failure: a qualitative study","volume":"85","author":"Driehuis","year":"2025","journal-title":"Am J Kidney Dis."},{"issue":"5 suppl 3","key":"B16-20260728","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/ajkd.1998.v32.pm9820462","article-title":"On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes","volume":"32","author":"Eknoyan","year":"1998","journal-title":"Am J Kidney Dis."},{"issue":"4 suppl 1","key":"B17-20260728","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0272-6386(00)70239-3","article-title":"Cardiovascular disease and chronic renal disease: a new paradigm","volume":"35","author":"Sarnak","year":"2000","journal-title":"Am J Kidney Dis."},{"issue":"17","key":"B18-20260728","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"B19-20260728","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2012.08.017","article-title":"A decade after the KDOQI CKD guidelines: impact on the cardiovascular disease-CKD paradigm","volume":"60","author":"Weiner","year":"2012","journal-title":"Am J Kidney Dis."},{"issue":"20","key":"B20-20260728","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"21","key":"B21-20260728","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA."},{"issue":"6","key":"B22-20260728","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation."},{"issue":"3","key":"B23-20260728","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ndt\/gfac140","article-title":"High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database","volume":"38","author":"Fried","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B24-20260728","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/dom.15194","article-title":"Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD registry, 2019-2020","volume":"25","author":"Nicholas","year":"2023","journal-title":"Diabetes Obes Metab."},{"issue":"6","key":"B25-20260728","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/j.ajkd.2025.06.019","article-title":"Targeting inflammation in CKD","volume":"86","author":"Nowak","year":"2025","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B26-20260728","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamacardio.2025.4588","article-title":"Prerenalism-A gap that costs lives, hearts, and kidneys","volume":"11","author":"Rangaswami","year":"2026","journal-title":"JAMA Cardiol."},{"issue":"7","key":"B27-20260728","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2215\/CJN.02980322","article-title":"Moving from evidence to implementation of breakthrough therapies for diabetic kidney disease","volume":"17","author":"Tuttle","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"key":"B28-20260728","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000001132","article-title":"Reimagining nephrology training in a cardiovascular-kidney-metabolic framework [published online ahead of print July 1, 2026]","author":"Tuttle","year":"2026","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4S","key":"B29-20260728","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"13","key":"B30-20260728","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA."},{"key":"B35-20260728","article-title":"2026 AHA\/ACC\/ADA\/ASN Guideline for the prevention, detection, evaluation and management of cardiovascular-kidney-metabolic syndrome: a report of the American college of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Ndumele","year":"2026","journal-title":"Circulation."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:27:42Z","timestamp":1787833662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001164"}},"subtitle":["Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives"],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001164","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}